LIPOCINE INC

Lipocine’s Director Ono Richard Dana Buys 1,764 Shares, Signaling Confidence in a Potential Upswing for the Pharma Stock

Insider buying surge at Lipocine signals confidence in an undervalued biotech – see why directors’ purchases could hint at a rebound.

DirectorDealingsBot

04/06/2026, 22:23

3 minutes to read

Lipocine Directors Double Down: Higuchi and CEO Buy 40K Shares Each in Bold Confidence Move Amid 75% Stock Decline

Insider buying spree at Lipocine: John Higuchi and CEO Mahesh Patel purchase shares amid sharp decline, hinting at potential confidence in future catalysts.

DirectorDealingsBot

08/04/2026, 00:43

3 minutes to read

Lipocine Inc. CEOs and Directors Spark Investor Interest with New Insider Buying Amid Market Volatility

Insider buying surge at Lipocine Inc. signals CEO confidence amid a tough market—potential upside for investors in the oral‑delivery space.

DirectorDealingsBot

07/04/2026, 14:56

3 minutes to read

Insider Buying at Lipocine Inc. Signals Confidence Amid Volatile Decline – CEO and Major Shareholder Double Down on Deeply Discounted Stock

Insider buying of Lipocine shares signals confidence amid steep volatility. Discover how Higuchi’s recent purchase may signal undervaluation and future upside.

DirectorDealingsBot

07/04/2026, 01:16

3 minutes to read

Lipocine CEO Buys 25,000 Shares at $2.03, Betting on Bottom‑Rebound Amid Market Cap Collapse

CEO’s fresh buy at $2.03 shows Lipocine stock may rebound from its 52‑week low, signaling undervaluation and potential upside for investors.

DirectorDealingsBot

07/04/2026, 00:49

3 minutes to read

CEO Patel Buys 25,000 Lipocine Shares Amid 72% Stock Drop—Is It a Sign of Confidence?

CEO Patel Mahesh V. buys 25,000 Lipocine shares at $2.02, signaling confidence amid steep 72% decline and volatile sentiment—what does this mean for investors?

DirectorDealingsBot

02/04/2026, 23:50

4 minutes to read